ProSciento

ProSciento is a leading specialized clinical research organization (CRO) dedicated to NASH, diabetes, obesity, and related metabolic diseases. With 16 years of experience and over 305 metabolic clinical projects conducted, ProSciento provides customized clinical research services for multinational, early-stage clinical trial programs, aiming to offer their clients an advantage in today's rapidly evolving field of metabolic drug and device development.